DIL
YARW

Deeter Investments LLP’s Yarrow Bioscience YARW Stock Holding History

Deeter Investments LLP’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$580K Buy
+20,000
New +$401K 0.12% 70

Other funds holding YARW

SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deeter Investments LLP's YARW Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Yarrow Bioscience (YARW) in Q4 2025: 20,000 shares worth $580K. The stake represents 0.12% of the portfolio and ranks #70 among its holdings.

42 funds tracked by Wall St. Rank hold YARW as of Q4 2025.

  • Deeter Investments LLP held 20,000 shares of Yarrow Bioscience worth $580K as of Q4 2025.
  • Yarrow Bioscience was a new Deeter Investments LLP position in Q4 2025.
  • Yarrow Bioscience made up 0.12% of Deeter Investments LLP's portfolio in Q4 2025, its #70 holding.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.